Syros Pharmaceuticals Inc (SYRS)
0.325
-0.03
(-9.70%)
USD |
NASDAQ |
Nov 14, 10:39
Syros Pharmaceuticals Market Cap: 8.721M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 9.657M |
| November 12, 2024 | 73.25M |
| November 11, 2024 | 86.67M |
| November 08, 2024 | 70.03M |
| November 07, 2024 | 68.69M |
| November 06, 2024 | 65.74M |
| November 05, 2024 | 67.89M |
| November 04, 2024 | 65.20M |
| November 01, 2024 | 60.78M |
| October 31, 2024 | 67.62M |
| October 30, 2024 | 67.35M |
| October 29, 2024 | 67.89M |
| October 28, 2024 | 56.62M |
| October 25, 2024 | 53.66M |
| October 24, 2024 | 55.54M |
| October 23, 2024 | 60.37M |
| October 22, 2024 | 66.28M |
| October 21, 2024 | 60.10M |
| October 18, 2024 | 52.59M |
| October 17, 2024 | 52.32M |
| October 16, 2024 | 51.25M |
| October 15, 2024 | 53.40M |
| October 14, 2024 | 52.86M |
| October 11, 2024 | 51.79M |
| October 10, 2024 | 52.32M |
| Date | Value |
|---|---|
| October 09, 2024 | 52.59M |
| October 08, 2024 | 53.66M |
| October 07, 2024 | 52.06M |
| October 04, 2024 | 52.59M |
| October 03, 2024 | 52.06M |
| October 02, 2024 | 51.79M |
| October 01, 2024 | 50.98M |
| September 30, 2024 | 57.69M |
| September 27, 2024 | 53.62M |
| September 26, 2024 | 52.55M |
| September 25, 2024 | 51.47M |
| September 24, 2024 | 51.74M |
| September 23, 2024 | 50.40M |
| September 20, 2024 | 52.28M |
| September 19, 2024 | 53.08M |
| September 18, 2024 | 53.08M |
| September 17, 2024 | 53.62M |
| September 16, 2024 | 53.08M |
| September 13, 2024 | 52.28M |
| September 12, 2024 | 42.09M |
| September 11, 2024 | 43.03M |
| September 10, 2024 | 41.82M |
| September 09, 2024 | 40.21M |
| September 06, 2024 | 40.62M |
| September 05, 2024 | 41.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.720M
Minimum
Nov 14 2024
840.15M
Maximum
Jan 19 2021
219.99M
Average
155.02M
Median
Jun 13 2024
Market Cap Benchmarks
| Baxter International Inc | 16.43B |
| AbbVie Inc | 299.34B |
| Elanco Animal Health Inc | 6.921B |
| Opus Genetics Inc | 28.03M |
| Entrada Therapeutics Inc | 735.77M |
Market Cap Related Metrics
| PS Ratio | 1.203 |
| Price | 0.325 |
| Earnings Yield | -944.6% |